FENBENDAZOLE ORAL DEWORMER- fenbendazole paste

FENBENDAZOLE Oral Dewormer by

Drug Labeling and Warnings

FENBENDAZOLE Oral Dewormer by is a Otc medication manufactured, distributed, or labeled by Shenzhen Zhenshangzekai Technology Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Febendazole

INACTIVE INGREDIENT

Glycerin, Magnesium Aluminum Silicate, Sodium Carboxymethylcellulose, Sorbitol, and Purified

Water.

KEEP OUT OF REACH OF CHILDREN

Keep out of the reach of children.

OTHER SAFETY INFORMATION

The antiparasitic efficacy is achieved through the systematic inhibition of energy metabolism

within the target parasites.

DOSAGE & ADMINISTRATION

Standard Therapeutic Dose:
2.3 mg/lb(5 mg/kg) of body weight.
Intensive Care Dose:
4.6 mg/lb(10 mg/kg) for specific larval stages or young animals.
Calibration Instructions:
1.Accurately assess the animal's weight prior to administration.
2. Remove the protective tip and rotate the dial ring to the zero position.
3. Advance the dial ring to the graduation corresponding to the measured weight.
4. Ensure the oral cavity is clear of food particles.
5. Administer the paste onto the back of the tongue by depressing the plunger firmly.
Yield: One 25g syringe provides a complete dose for a 1,100 lb animal at the standard 5 mg/kg
rate.

PURPOSE

dewormer

WARNINGS

Human Safety: NOT FOR USE IN HUMANS.
· Food Safety: Do not use in animals intended for human consumption.
· Animal Care: Safety in pregnant animals or breeding stallions at the 10 mg/kg dosage for 5
days has not been specifically evaluated.
· Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.
Resistance Management:
Fecal examinations and diagnostic monitoring are recommended to maintain long-term efficacy
and manage parasite resistance.
Environmental & Storage Conditions:
· Store at or below 25°C (77℉) in a temperature-controlled environment.
· Keep the syringe tightly capped when not in use.

INDICATIONS & USAGE

Indicated for the clinical management of:
Large Strongyles: (Strongylus edentatus, S. equinus, S. vulgaris).
Small Strongyles: Including various larval stages (encysted early 3rd stage, late 3rd stage, and 4th
stage cyathostome larvae).
Ascarids / Roundworms: (Parascaris equorum).
Pinworms: (Oxyuris equi).

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

FENBENDAZOLE ORAL DEWORMER 
fenbendazole paste

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87276-263
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
FENBENDAZOLE (UNII: 621BVT9M36) (FENBENDAZOLE - UNII:621BVT9M36)	FENBENDAZOLE	100 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
AQUA (UNII: 059QF0KO0R)
SORBITOL (UNII: 506T60A25R)
GLYCERIN (UNII: PDC6A3C0OX)
MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87276-263-00	1 g in 1 TUBE; Type 0: Not a Combination Product	03/17/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M024	03/17/2026

Labeler - Shenzhen Zhenshangzekai Technology Co., Ltd. (518601007)